135 related articles for article (PubMed ID: 9264242)
21. New 3-benzisothiazolyl and 3-benzisoxazolylpiperazine derivatives with atypical antipsychotic binding profile.
Orjales A; Mosquera R; Toledo A; Pumar C; Labeaga L; Innerárity A
Eur J Med Chem; 2002 Sep; 37(9):721-30. PubMed ID: 12350289
[TBL] [Abstract][Full Text] [Related]
22. 2-aminotetralin-derived substituted benzamides with mixed dopamine D2, D3, and serotonin 5-HT1A receptor binding properties: a novel class of potential atypical antipsychotic agents.
Homan EJ; Copinga S; Elfström L; van der Veen T; Hallema JP; Mohell N; Unelius L; Johansson R; Wikström HV; Grol CJ
Bioorg Med Chem; 1998 Nov; 6(11):2111-26. PubMed ID: 9881101
[TBL] [Abstract][Full Text] [Related]
23. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
Ransom RW; Asarch KB; Shih JC
J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
[TBL] [Abstract][Full Text] [Related]
24. New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D(2)-receptor and serotonin 5-HT(1A)-receptor affinities.
Feenstra RW; de Moes J; Hofma JJ; Kling H; Kuipers W; Long SK; Tulp MT; van der Heyden JA; Kruse CG
Bioorg Med Chem Lett; 2001 Sep; 11(17):2345-9. PubMed ID: 11527728
[TBL] [Abstract][Full Text] [Related]
25. Serotonergic ergoline derivatives.
Mantegani S; Brambilla E; Caccia C; Damiani G; Fornaretto MG; McArthur RA; Varasi M
Bioorg Med Chem Lett; 1998 May; 8(9):1117-22. PubMed ID: 9871719
[TBL] [Abstract][Full Text] [Related]
26. Functional characteristics of a series of N4-substituted 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazines as 5-HT1A receptor ligands. Structure-activity relationships.
van Steen BJ; van Wijngaarden I; Ronken E; Soudijn W
Bioorg Med Chem Lett; 1998 Sep; 8(18):2457-62. PubMed ID: 9873561
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
Chloń G; Pawłowski M; Duszyńska B; Szaro A; Tatarczńska E; Kłodzińska AL; Chojnacka-Wójcik E
Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
[TBL] [Abstract][Full Text] [Related]
28. A series of N4-imidoethyl derivatives of 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine as 5-HT1A receptor ligands: synthesis and structure-affinity relationships.
van Steen BJ; van Wijngaarden I; Tulp MT; Soudijn W
J Med Chem; 1995 Oct; 38(21):4303-8. PubMed ID: 7473558
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of a series of 6-substituted-2-pyridinylmethylamine derivatives as novel, high-affinity, selective agonists at 5-HT1A receptors.
Vacher B; Bonnaud B; Funes P; Jubault N; Koek W; Assié MB; Cosi C
J Med Chem; 1998 Dec; 41(25):5070-83. PubMed ID: 9836623
[TBL] [Abstract][Full Text] [Related]
30. Influence of the terminal amide fragment geometry in some 3-arylideneindolin-2(1H)-ones on their 5-HT1A/5-HT2A receptor activity.
Mokrosz MJ; Charakchieva-Minol S; Kozioł A; Kłodzińska A; Chojnacka-Wójcik E
Bioorg Med Chem Lett; 2001 May; 11(9):1229-31. PubMed ID: 11354383
[TBL] [Abstract][Full Text] [Related]
31. 1-aryl-4-[(1-tetralinyl)alkyl]piperazines: alkylamido and alkylamino derivatives. Synthesis, 5-HT1A receptor affinity, and selectivity. 3.
Perrone R; Berardi F; Leopoldo M; Tortorella V; Fornaretto MG; Caccia C; McArthur RA
J Med Chem; 1996 Aug; 39(16):3195-202. PubMed ID: 8759642
[TBL] [Abstract][Full Text] [Related]
32. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
[TBL] [Abstract][Full Text] [Related]
33. 1,2,5-Thiadiazole derivatives are potent and selective ligands at human 5-HT1A receptors.
Sabb AL; Vogel RL; Kelly MG; Palmer Y; Smith DL; Andree TH; Schechter LE
Bioorg Med Chem Lett; 2001 Apr; 11(8):1069-71. PubMed ID: 11327592
[TBL] [Abstract][Full Text] [Related]
34. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors.
Przegaliński E; Filip M; Bijak M; Wedzony K; Budziszewska B; Tokarski K; Maćkowiak M; Fijał K
Pol J Pharmacol; 1996; 48(1):13-22. PubMed ID: 9112623
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and alpha(1)-adrenoceptor binding properties of new arylpiperazine derivatives bearing a flavone nucleus as the terminal heterocyclic molecular portion.
Betti L; Floridi M; Giannaccini G; Manetti F; Paparelli C; Strappaghetti G; Botta M
Bioorg Med Chem; 2004 Mar; 12(6):1527-35. PubMed ID: 15018926
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationship studies of CNS agents, Part 31: Analogs of MP 3022 with a different number of nitrogen atoms in the heteroaromatic fragment--new 5-HT1A receptor ligands.
Paluchowska MH; Dereń-Wesołek A; Mokrosz JL; Charakchieva-Minol S; Chojnacka-Wójcik E
Arch Pharm (Weinheim); 1996 Oct; 329(10):451-6. PubMed ID: 8933747
[TBL] [Abstract][Full Text] [Related]
37. Activation of 5-HT1A receptors potentiates the clonidine inhibitory effect in the locus coeruleus.
Ruiz-Ortega JA; Ugedo L
Eur J Pharmacol; 1997 Aug; 333(2-3):159-62. PubMed ID: 9314029
[TBL] [Abstract][Full Text] [Related]
38. Interaction of 1,2,4-substituted piperazines, new serotonin receptor ligands, with 5-HT1A and 5-HT2A receptors.
Chilmonczyk Z; Cybulski M; Iskra-Jopa J; Chojnacka-Wójcik E; Tatarczyńska E; Kłodzińska A; Leś A; Bronowska A; Sylte I
Farmaco; 2002 Apr; 57(4):285-301. PubMed ID: 11989808
[TBL] [Abstract][Full Text] [Related]
39. Further characterization of 5-HT1A receptors in the goldfish retina: role of cyclic AMP in the regulation of the in vitro outgrowth of retinal explants.
Schmeer C; Obregón F; Urbina M; Lima L
Neurochem Res; 2001 Mar; 26(3):213-23. PubMed ID: 11495544
[TBL] [Abstract][Full Text] [Related]
40. Effect of linking bridge modifications on the 5-HT1A receptor activity of some 4-(omega-benzotriazol-1-yl)alkyl-1-(2-methoxy-phenyl)piperazines.
Paluchowska MH; Kłodzińska A; Tatarczyńska E; Szaro A; Chojnacka-Wójcik E
Pol J Pharmacol; 1998; 50(4-5):341-7. PubMed ID: 10091719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
